跳至主要内容
临床试验/NCT04595578
NCT04595578已完成不适用

Effect of Repetitive Transcranial Magnetic Stimulation With Intensive Physical Therapy in Cerebellar Ataxia: A Pilot Study

Samsung Medical Center2 个研究点 分布在 2 个国家目标入组 34 人开始时间: 2017年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
34
试验地点
2
主要终点
International Cooperative Ataxia Rating Scale (ICARS)

研究概览

简要总结

The present study investigated the efficacy and safety of combination treatment of repetitive transcranial magnetic stimulation (rTMS) and physical therapy (PT) in patients with cerebellar variant of multiple system atrophy (MSA-C) and spinocerebellar ataxia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patients with probable MSA-C and spinocerebellar ataxia (SCA)
  • cerebellar ataxia as main clinical presenting feature and able to walk independently without walking devices
  • aged over 20
  • presence of cerebellar atrophy proven by brain MRI.

排除标准

  • secondary cerebellar ataxia
  • peripheral neuropathy, radiculopathy, or decreased visual acuity that can cause peripheral ataxia
  • musculoskeletal disease affecting gait or balance
  • other neurologic symptoms, including symptomatic parkinsonism (two or more rigidity and/or bradykinesia scores in one limb by Unified Parkinson's disease Rating Scale part 3) or spasticity (20)
  • psychiatric symptoms requiring medication or with cognitive decline (Mini-mental state examination [MMSE] < 20)
  • taking any sedative medications or anti-parkinsonian medications such as benzodiazepine, levodopa or dopamine agonist
  • history of seizure or metallic brain implants; (8) cardiopulmonary diseases causing dyspnea during exercise.

结局指标

主要结局

International Cooperative Ataxia Rating Scale (ICARS)

时间窗: The change of ICARS score between baseline (T0) and immediately after (T1) treatment

The scale is scored out of 100 with 19 items and 4 subscales of postural and gait disturbances, limb ataxia, dysarthria, and oculomotor disorders. Higher scores indicate higher levels of impairment.

次要结局

  • Change from Mini-Mental State Examination (MMSE)(The clinical scales were evaluated by blinded raters at baseline (T0) and immediately after (T1), 4 weeks after (T2), and 12 weeks (T3) after intervention.)
  • Change from Beck depression inventory (BDI)(The clinical scales were evaluated by blinded raters at baseline (T0) and immediately after (T1), 4 weeks after (T2), and 12 weeks (T3) after intervention.)
  • Change from temporospatial parameters of gait(The clinical scales were evaluated by blinded raters at baseline (T0) and immediately after (T1), 4 weeks after (T2), and 12 weeks (T3) after intervention.)
  • Change from Barthel Index for Activities of Daily Living(The clinical scales were evaluated by blinded raters at baseline (T0) and immediately after (T1), 4 weeks after (T2), and 12 weeks (T3) after intervention.)
  • Change from posturography(The clinical scales were evaluated by blinded raters at baseline (T0) and immediately after (T1), 4 weeks after (T2), and 12 weeks (T3) after intervention.)
  • Change from International Cooperative Ataxia Rating Scale (ICARS)(The clinical scales were evaluated by blinded raters at baseline (T0) and 4 weeks after (T2), and 12 weeks (T3) after intervention.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jinyoung Youn

Associate Professor

Samsung Medical Center

研究点 (2)

Loading locations...

相似试验